NEPHROPLUS749.20

Nephrocare Health Services Limited

· Pharma & Health
₹ CrorePeersKRSNAASURAKSHAHEALTHX3BBLACKBIOMcap ₹7,517 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Returns
Return on Common Equity6.88
Return on Assets5.22
Return on Capital Employed11.63
Return on Invested Capital12.01
Margins
EBITDA Margin22.72
Operating Margin13.65
Pretax Margin10.07
Net Income Margin7.69
Net Income to Common Margin7.69
FCF Margin11.33
Additional
Effective Tax Rate20.52
Sustainable Growth Rate6.88
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.